Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

✍ Scribed by Ogura, M.; Ishida, T.; Hatake, K.; Taniwaki, M.; Ando, K.; Tobinai, K.; Fujimoto, K.; Yamamoto, K.; Miyamoto, T.; Uike, N.; Tanimoto, M.; Tsukasaki, K.; Ishizawa, K.; Suzumiya, J.; Inagaki, H.; Tamura, K.; Akinaga, S.; Tomonaga, M.; Ueda, R.

• Book ID: 127352810
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 139 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2013.52.0924